# OnCo record nct04224493 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct04224493/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct04224493", "NCT04224493" ;
  schema:name "A Study to Assess the Efficacy, Safety, Pharmacodynamics, and Pharmacokinetics of Tazemetostat in Combination With Lenalidomide Plus Rituximab Versus "@en ;
  schema:alternateName "Symphony-1"@en ;
  schema:description "A phase 3 trial of Tazemetostat, Lenalidomide, Rituximab in follicular lymphoma, run by Epizyme, Inc., active and no longer recruiting."@en ;
  schema:url <https://onco.cc/trials/nct04224493/> ;
  schema:dateModified "2026-09-16"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT04224493> ;
  onco:status "active" ;
  onco:tag "ctgov-ingest" ;
  onco:phase "3" ;
  schema:startDate "2020-06-11" ;
  onco:cancers <https://onco.cc/cancers/follicular-lymphoma/> ;
  onco:technologies <https://onco.cc/technologies/epigenetic-drugs/>, <https://onco.cc/technologies/monoclonal-antibody/>, <https://onco.cc/technologies/protac-degrader/> ;
  onco:drugs <https://onco.cc/drugs/tazemetostat/>, <https://onco.cc/drugs/lenalidomide/>, <https://onco.cc/drugs/rituximab/> ;
  onco:companies <https://onco.cc/companies/ipsen/> .